Next Article in Journal / Special Issue
Pigment Epithelium-Derived Factor (PEDF) is a Determinant of Stem Cell Fate: Lessons from an Ultra-Rare Disease
Previous Article in Journal / Special Issue
On the Origin of Cells
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
JDB
Volume 3
Issue 4
10.3390/jdb3040093
jdb-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Pbx4 is Required for the Temporal Onset of Zebrafish Myocardial Differentiation

by
Robert M. Kao
1,
Joel G. Rurik
1,
Gist H. Farr III
1,
Xiu Rong Dong
1,
Mark W. Majesky
1,2,* and
Lisa Maves
1,2,*
1
Center for Developmental Biology and Regenerative Medicine, Seattle Children’s Research Institute, 1900 9th Avenue, Seattle, WA 98101, USA
2
Division of Cardiology, Department of Pediatrics, University of Washington, Seattle, WA 98105, USA
*
Authors to whom correspondence should be addressed.
J. Dev. Biol. 2015, 3(4), 93-111; https://doi.org/10.3390/jdb3040093
Submission received: 26 September 2015 / Revised: 24 October 2015 / Accepted: 5 November 2015 / Published: 12 November 2015
(This article belongs to the Special Issue Cell Fate Decisions in Development and Disease)
Browse Figures
Versions Notes

Abstract

:
Proper control of the temporal onset of cellular differentiation is critical for regulating cell lineage decisions and morphogenesis during development. Pbx homeodomain transcription factors have emerged as important regulators of cellular differentiation. We previously showed, by using antisense morpholino knockdown, that Pbx factors are needed for the timely activation of myocardial differentiation in zebrafish. In order to gain further insight into the roles of Pbx factors in heart development, we show here that zebrafish pbx4 mutant embryos exhibit delayed onset of myocardial differentiation, such as delayed activation of tnnt2a expression in early cardiomyocytes in the anterior lateral plate mesoderm. We also observe delayed myocardial morphogenesis and dysmorphic patterning of the ventricle and atrium, consistent with our previous Pbx knock-down studies. In addition, we find that pbx4 mutant larvae have aberrant outflow tracts and defective expression of the proepicardial marker tbx18. Finally, we present evidence for Pbx expression in cardiomyocyte precursors as well as heterogeneous Pbx expression among the pan-cytokeratin-expressing proepicardial cells near the developing ventricle. In summary, our data show that Pbx4 is required for the proper temporal activation of myocardial differentiation and establish a basis for studying additional roles of Pbx factors in heart development.

Graphical Abstract

1. Introduction

Temporal control of cellular differentiation is essential for animal development. During cardiac development, timely activation of cardiomyocyte differentiation genes is needed for the proper morphogenetic formation of ventricular and atrial cardiac chambers [1,2]. In zebrafish cardiac development, cardiomyocyte differentiation is tightly linked with the morphogenetic movements needed for the bilateral cardiac primordia to undergo cell migration and fuse at the midline to form the heart tube [1,3,4,5]. Understanding the mechanisms behind cardiomyocyte differentiation are, thus, critical to understanding how the heart forms.
Recent studies have implicated Pbx homeodomain pioneer transcription factors and their Meis cofactor partners as critical regulators of heart development [6,7,8,9,10,11]. Pbx and Meis encode TALE (Three Amino acid Loop Extension)-class homeodomain-containing DNA-binding proteins. In mice and zebrafish, multiple Pbx genes are broadly expressed [12,13]. Well-characterized as cofactors for Hox proteins, Pbx/Meis also act as pioneer factors for Myod to promote skeletal muscle differentiation [14,15,16]. We previously showed, using antisense morpholinos (MOs) to knock down pbx2 and pbx4, that pbx2-MO;pbx4-MO zebrafish embryos have delayed activation of cardiomyocyte differentiation [8]. The delayed differentiation and migration of myocardial precursor cells leads to defective myocardial morphogenesis and chamber formation in pbx2-MO;pbx4-MO embryos [8]. Our studies on heart and skeletal muscle support a model whereby Pbx proteins provide competence to respond to cell-lineage transcription factors to direct cellular differentiation programs.
In mice, Pbx1/2/3 and Meis1 are required for outflow tract development [6,7]. These studies showed that Pbx proteins act in neural crest cells to promote Pax3 expression necessary for outflow tract development [7]. However, other studies have suggested roles for Pbx/Meis proteins within cardiomyocytes. We previously demonstrated that Pbx/Meis proteins can directly bind the promoter of the myocardial differentiation gene myl7 in vitro [8]. Postnatally in mice, Meis1 is expressed in cardiomyocytes and promotes cardiomyocyte cell-cycle arrest [11]. PBX/MEIS binding sites are enriched in open chromatin in cardiac progenitor cell culture models, and Pbx binding sites are also associated with Tbx5 binding sites [9,10,17]. In spite of these studies, the requirements for Pbx factors in heart development have not yet been fully addressed.
Here, we present evidence that zebrafish pbx4 mutant embryos display delayed onset of myocardial differentiation and morphogenesis, resembling the previously characterized zebrafish pbx2/4 morpholino-knockdown phenotype [8]. Furthermore, we also demonstrate that pbx4 is required for establishing a proper outflow tract and proepicardium, which gives rise to the epicardial mesothelium surrounding the heart. Finally, we provide evidence of Pbx expression in cardiomyocyte precursors and of heterogeneous Pbx expression in pan-cytokeratin-expressing proepicardial cells near the ventricle. Taken together, our results provide further evidence that Pbx proteins promote myocardial differentiation and suggest multiple roles for Pbx proteins in heart development.

2. Experimental Section

2.1. Zebrafish Husbandry

All experiments involving live zebrafish (Danio rerio) were carried out in compliance with Seattle Children’s Research Institute IACUC guidelines. Zebrafish were raised and staged as previously described [18]. Staging time refers to hours post fertilization (hpf) at 28.5 °C. In some cases, embryos were raised for periods at 24 °C. For studies prior to 24 hpf, somite (s) number was used for staging, and mutant and control embryos were somite-stage matched. In some cases, embryos were incubated in 1-phenyl-2-thiourea to inhibit pigmentation [18]. The wild-type stock and genetic background used was AB. The pbx4b557 mutant strain was previously described and is likely a null allele [19]. pbx4b557 genotyping was performed using forward primer 5′ACTCGGCGGACTCTCGCAAGC3′ and reverse primer 5′GGCTCTCGTCGGTGATGGCCATGATCT3′. The genotyping PCR product is 128 base pairs, and digesting with XbaI yields a 98 base pair product from the mutant allele. The Tg(myh6:EGFP)s958, Tg(myl7:EGFP)twu34, and Tg(myl7:h2afva-mCherry)sd12 strains have been described [20,21,22].

2.2. Whole-mount RNA in Situ Hybridization

The following cDNA probes were used: krox20 (egr2b-Zebrafish Information Network) [23]; tnnt2a [24]; myl7 [25]; vmhc [25]; myh6 [26]; nppa [26]; gata4 [27]; gata5 [27]; hand2 [28]; elnb [29]; tbx18 (MGC:194980); and ltbp3 [30]. Whole-mount in situ hybridization colorimetric and fluorescent in situ staining was performed as previously described [15,31], with the following modifications. For colorimetric NBT/BCIP stained embryos, dimethylformamide was used prior to stepwise glycerol clearing to 80% glycerol in 1X PBS. Antisense RNA probes for either colorimetric or fluorescent in situ hybridization experiments were diluted into 5% dextran sulfate hybridization buffer. To reduce non-specific colorimetric staining at 48 hpf and later stages, we immediately processed 4% PFA/1X PBS-fixed embryos for de-pigmentation using 1 part 0.1% KOH (vol.): 1 part 1X PBS-0.1% Tween (vol.): 0.1 part 30% hydrogen peroxide (vol.) for 3–4 h at room temperature with gentle agitation. After 1 µg/mL proteinase K digestion and post-fixation steps, 48 hpf and later stages were then stored in pre-hybridization buffer at −20 °C overnight until further use. Following staining and imaging, tail clips from post-in situ hybridized embryos were lysed and genotyped for pbx4 as above.

2.3. Whole-mount Zebrafish Immunostaining and Cardiomyocyte Cell Counting

Whole-embryo immunostaining was performed with the following primary antibodies: anti-Pbx (1:100, rabbit antisera, [32]), MF20 (1:50, supernatant, Developmental Studies Hybridoma Bank, University of Iowa), anti-GFP (1:500, Roche #11814460001), anti-mCherry (1:500, Rockland Antibodies & Assays #600-401-P16), anti-GFP (1:500, Abcam ab13970), and pan-cytokeratin (1:100, Sigma C2562). Secondary antibodies were goat anti-rabbit 568 (1:800, Life Technologies #A-11011), goat anti-rabbit 594 (1:500, Life Technologies #R37117), goat anti-chicken 488 (1:500, Life Technologies #A-11039), and goat anti-mouse 488 (1:800, Life Technologies #A-11029). Whole-mount immunostaining was performed as previously described [33]. For anti-Pbx staining at 48 hpf and for anti-pan-cytokeratin staining, Dent’s fixative (cold 80% methanol and 20% DMSO; [34]) was used with overnight fixation at 4 °C, and a modified whole-mount staining protocol was used [35].
Cardiomyocyte nuclei were counted using Tg(myl7:h2afva-mCherry)sd12 [21] in pbx4b557-/- and control sibling embryos. 26 hpf embryos were immunostained and whole mounted in 100% glycerol. 48 hpf embryo hearts were removed after immunostaining via microdissection and mounted in 30% glycerol/70% PBS-0.1% Tween. Nuclei were counted using ImageJ software [36]. Cell number data were analyzed using a Student’s t-test (2-tailed, equal variance).

2.4. Fluorescent Confocal Microscopy and Stereoscope Imaging

Fluorescent confocal microscopy (Leica SP5) was used for examining embryos using a 20X air objective (NA = 0.7). In instances where longer working distances were necessary, fluorescently stained specimens were imaged with an upright Olympus fluorescent single photon confocal equipped with a 20X water-dipping objective (NA = 0.95). For 12 s and 16 s stage fluorescent RNA in situ, ImageJ was used for pairwise stitching of original optical stacks taken with 20X air objective (NA = 0.7), using the method previously described [37].

3. Results

3.1. Zebrafish Pbx4 Mutants Exhibit Defective Heart Function

Pöpperl et al. [19] previously described pbx4b557 mutant embryos as having a swollen pericardium and thin, weakly beating heart, and we showed that pbx2-MO;pbx4-MO embryos also have pericardial edema and decreased heart rate [8]. We confirmed that pbx4b557 mutant embryos have pericardial edema and exhibit blood pooled by the atrium (Figure 1B). We assessed heart rates and found that while control 50 hpf sibling embryos had 135 ± 11 beats/min (n = 14), pbx4b557 mutant embryos had 105 ± 14 beats/min (n = 13). Thus, zebrafish Pbx4 is needed for proper heart development and function, consistent with the previous studies [8,19].
Jdb 03 00093 g001 1024
Figure 1. Defective heart development in pbx4 mutant embryos. (A,B) Lateral views of live (A) control and (B) pbx4b557-/- embryos at 50 h post fertilization (hpf). pbx4b557 mutant embryos show pericardial edema (arrow in B) and blood pooled near the atrium (arrowhead in B). a, atrium. For controls, n = 23. pbx4b557 mutant embryos (n = 20) all show similar phenotypes as in (B). Anterior is to the left.
Figure 1. Defective heart development in pbx4 mutant embryos. (A,B) Lateral views of live (A) control and (B) pbx4b557-/- embryos at 50 h post fertilization (hpf). pbx4b557 mutant embryos show pericardial edema (arrow in B) and blood pooled near the atrium (arrowhead in B). a, atrium. For controls, n = 23. pbx4b557 mutant embryos (n = 20) all show similar phenotypes as in (B). Anterior is to the left.
Jdb 03 00093 g001

3.2. Pbx4 is Required for Proper Temporal Onset of Cardiac Muscle Differentiation

To determine whether Pbx4 is required for the initiation of myocardial differentiation, we examined the onset of expression of early myocardial differentiation genes in pbx4b557 mutant embryos. At the 12 somite (12 s) stage (15 hpf), cardiac troponin T type 2a (tnnt2a) is absent or very reduced in cardiomyocyte precursors in the anterior lateral plate mesoderm (ALPM) of pbx4b557-/- embryos compared to control embryos (Figure 2A,B). By 16 s (17 hpf), tnnt2a expression is still reduced in pbx4b557-/- embryos compared to controls (Figure 2C,D). Two other early myocardial differentiation genes, pan-myocardial myl7, and ventricular vmhc [25], are also absent or very reduced in the ALPM of pbx4b557-/- embryos at 16 s (Figure 2E–H). At the time of fusion of bilateral cardiomyocyte populations at 21 s (19.5 hpf), the majority of pbx4b557-/- embryos display delayed fusion of myl7-expressing cardiac primordia (6/7 embryos not fused, Figure 2J), compared to controls (1/13 embryos not fused, Figure 2I). Similarly, pbx4b557-/- embryos display non-fused domains of vmhc-expressing cells (6/7 embryos not fused, Figure 2L) compared to controls (2/18 not fused, Figure 2K). Finally, analysis of atrial myh6-expressing cardiomyocyte precursors revealed pbx4b557-/- embryos with non-fused and diminished expression (4/5 embryos not fused, Figure 2N) compared to controls (3/17 not fused, Figure 2M). To determine whether the delayed cardiac primordia midline fusion phenotype at 21 s was due to a myocardial morphogenesis defect and not a general developmental delay of pbx4b557-/- embryos, we assayed these cardiomyocyte markers at 27 s (22.5 hpf). We find that pbx4b557-/- embryos continue to display dysmorphic patterning of myl7, vmhc, and myh6 expression domains compared to controls (Figure 2O–T). In particular, myocardial domains in 27 s pbx4b557-/- embryos can remain not fused or show anterior rather than normal posterior fusion ([4]; Figure 2O–U). These data are consistent with a delayed initiation of myocardial differentiation and subsequent morphogenesis defect of cardiomyocyte primordia in pbx4b557-/- embryos.
To further investigate the myocardial differentiation defects in pbx4b557-/- embryos, we examined expression of nppa, a myocardial differentiation gene whose expression is absent in pbx2-MO;pbx4-MO embryos [8]. nppa initially turns on at about 24 hpf in control embryos [8]. At 27 hpf, nppa expression is reduced in pbx4b557-/- embryos (Figure 2V,W), although it does not appear as strongly reduced as was observed in pbx2-MO;pbx4-MO embryos [8]. Taken together, these results show that the myocardial differentiation phenotype in pbx4b557-/- embryos is similar to, although possibly not as severe as, the myocardial differentiation phenotype we previously characterized in pbx2-MO;pbx4-MO embryos [8].
Jdb 03 00093 g002a 1024Jdb 03 00093 g002b 1024
Figure 2. Delayed onset of cardiomyocyte differentiation genes in pbx4 mutant embryos. (A–T, V–W) RNA in situ expression of cardiomyocyte differentiation genes (A–D) tnnt2a, (E–F, I–J, O–P) myl7, (G–H, K–L, Q–R) vmhc, (M–N, S–T) myh6, and (V–W) nppa in (A,C,E,G,I,K,M,O,Q,S,V) control and (B,D,F,H,J,L,N,P,R,T,W) pbx4b557-/- embryos. Developmental stages are indicated. Embryos are shown in dorsal view, anterior towards the left. (A–H) Expression of the Pbx-dependent gene krox20, marking rhombomeres 3 and 5 (r3, r5 in A) in the hindbrain, was included to distinguish between control and pbx4b557-/- mutants [12,19]. Expression of myod, which is expressed in a stripe in each somite plus two additional pre-somitic stripes [38], was included for somite staging. Arrows indicate ALPM expression domains of cardiomyocyte differentiation genes. (A,B) At 12 s, tnnt2a is absent or reduced in pbx4b557-/- embryos (n = 8; 6/8 absent, 2/8 reduced) compared to controls (n = 30; all similar). (C,D) at 16 s, tnnt2a is reduced in pbx4b557-/- embryos (n = 7) compared to controls (n = 28). (E,F) at 16 s, myl7 is absent or reduced in pbx4b557-/- embryos (n = 9; 3/9 absent, 6/9 reduced) compared to controls (n = 22). (G,H) at 16 s, vmhc is absent or reduced in pbx4b557-/- embryos (n = 6; 1/6 absent, 5/6 reduced) compared to controls (n = 10). (I–T) At 21 s and 27 s, myl7, vmhc, and myh6 show delayed fusion and abnormal patterning of expression domains in pbx4b557-/- embryos compared to controls. For (I–N), numbers of affected embryos are provided in the text. For (O–T), numbers of affected embryos are graphed in (U). Arrows indicate expression domains of cardiomyocyte differentiation genes. (U) Graph displaying percentage of embryos at 27 s with either normally patterned (blue), dysmorphic or unfused (green), or anteriorly fused (purple) cardiac primordia. (V–W) At 27 hpf, nppa is reduced in pbx4b557-/- embryos (n = 4, all similar reduced expression) compared to controls (n = 24). Arrows indicate myocardial expression domains.
Figure 2. Delayed onset of cardiomyocyte differentiation genes in pbx4 mutant embryos. (A–T, V–W) RNA in situ expression of cardiomyocyte differentiation genes (A–D) tnnt2a, (E–F, I–J, O–P) myl7, (G–H, K–L, Q–R) vmhc, (M–N, S–T) myh6, and (V–W) nppa in (A,C,E,G,I,K,M,O,Q,S,V) control and (B,D,F,H,J,L,N,P,R,T,W) pbx4b557-/- embryos. Developmental stages are indicated. Embryos are shown in dorsal view, anterior towards the left. (A–H) Expression of the Pbx-dependent gene krox20, marking rhombomeres 3 and 5 (r3, r5 in A) in the hindbrain, was included to distinguish between control and pbx4b557-/- mutants [12,19]. Expression of myod, which is expressed in a stripe in each somite plus two additional pre-somitic stripes [38], was included for somite staging. Arrows indicate ALPM expression domains of cardiomyocyte differentiation genes. (A,B) At 12 s, tnnt2a is absent or reduced in pbx4b557-/- embryos (n = 8; 6/8 absent, 2/8 reduced) compared to controls (n = 30; all similar). (C,D) at 16 s, tnnt2a is reduced in pbx4b557-/- embryos (n = 7) compared to controls (n = 28). (E,F) at 16 s, myl7 is absent or reduced in pbx4b557-/- embryos (n = 9; 3/9 absent, 6/9 reduced) compared to controls (n = 22). (G,H) at 16 s, vmhc is absent or reduced in pbx4b557-/- embryos (n = 6; 1/6 absent, 5/6 reduced) compared to controls (n = 10). (I–T) At 21 s and 27 s, myl7, vmhc, and myh6 show delayed fusion and abnormal patterning of expression domains in pbx4b557-/- embryos compared to controls. For (I–N), numbers of affected embryos are provided in the text. For (O–T), numbers of affected embryos are graphed in (U). Arrows indicate expression domains of cardiomyocyte differentiation genes. (U) Graph displaying percentage of embryos at 27 s with either normally patterned (blue), dysmorphic or unfused (green), or anteriorly fused (purple) cardiac primordia. (V–W) At 27 hpf, nppa is reduced in pbx4b557-/- embryos (n = 4, all similar reduced expression) compared to controls (n = 24). Arrows indicate myocardial expression domains.
Jdb 03 00093 g002aJdb 03 00093 g002b

3.3. Early Myocardial Specification is Not Reduced in Pbx4b557-/- Embryos

We previously showed in pbx2-MO;pbx4-MO embryos that, while myocardial differentiation is reduced, myocardial specification appears normal [8]. We, therefore, investigated early myocardial specification in pbx4b557-/- embryos. We find that myocardial specification genes gata4, gata5, and hand2 are robustly expressed in pbx4b557-/- embryos at 10 s (Figure 3). In particular, we observe an expanded domain of hand2 expression, similar to what we previously reported in pbx2-MO;pbx4-MO and hand2-MO embryos (Figure 3E,F) [8]. These results show that, in contrast to myocardial differentiation markers, myocardial specification markers do not show reduced expression in pbx4b557-/- embryos.
Jdb 03 00093 g003 1024
Figure 3. Early cardiomyocyte specification does not appear reduced in pbx4 mutant embryos. (A–F) RNA in situ expression at the 10 s stage of cardiomyocyte specification genes (A–B) gata4, (C–D) gata5, and (E–F) hand2 in the anterior lateral plate mesoderm (ALPM) in (A,C,E) control and (B,D,F) pbx4b557-/- embryos. Expression of the Pbx-dependent gene krox20, marking hindbrain rhombomeres 3 and 5 (r3, r5 in A), was included to distinguish between control and pbx4b557-/- embryos [12,19]. Arrows indicate ALPM expression domains in control embryos. The junction between hand2-expressing ALPM and posterior lateral plate mesoderm domains is noted by arrowheads (E). For (A–D), n ≥ 10 for each marker in pbx4b557-/- embryos and n ≥ 30 for each marker in control embryos, all with similar expression patterns. For (E–F), pbx4b557-/- embryos display expanded hand2 expression (n = 14; 13/14 with expanded expression) compared to control embryos (n = 47; all similar). Embryos are shown in dorsal view, anterior towards the left.
Figure 3. Early cardiomyocyte specification does not appear reduced in pbx4 mutant embryos. (A–F) RNA in situ expression at the 10 s stage of cardiomyocyte specification genes (A–B) gata4, (C–D) gata5, and (E–F) hand2 in the anterior lateral plate mesoderm (ALPM) in (A,C,E) control and (B,D,F) pbx4b557-/- embryos. Expression of the Pbx-dependent gene krox20, marking hindbrain rhombomeres 3 and 5 (r3, r5 in A), was included to distinguish between control and pbx4b557-/- embryos [12,19]. Arrows indicate ALPM expression domains in control embryos. The junction between hand2-expressing ALPM and posterior lateral plate mesoderm domains is noted by arrowheads (E). For (A–D), n ≥ 10 for each marker in pbx4b557-/- embryos and n ≥ 30 for each marker in control embryos, all with similar expression patterns. For (E–F), pbx4b557-/- embryos display expanded hand2 expression (n = 14; 13/14 with expanded expression) compared to control embryos (n = 47; all similar). Embryos are shown in dorsal view, anterior towards the left.
Jdb 03 00093 g003

3.4. Pbx4 is Required for Cardiac Chamber Morphogenesis, Proper Outflow Tract Development, and Proepicardial Development

Our previous analyses showed that pbx2-MO;pbx4-MO embryos have dysmorphic ventricular and atrial chambers [8]. We examined pbx4b557-/- embryos and found that they also had dysmorphic chambers (Figure 4A,B). In particular, we observe variable bulges in the ventricle (arrow in Figure 4B; also see Figure 4F,I,J). These dysmorphic chambers are similar to what we observed in pbx2-MO;pbx4-MO embryos and may be due, at least in part, to the delayed and abnormal heart tube morphogenesis (Figure 2) [8]. To assess the basis of this chamber dysmorphogenesis, we counted cardiomyocytes at two stages, 26 hpf and 48 hpf, using the transgenic strain Tg(myl7:h2afva-mCherry)sd12, which labels all myocardial nuclei [21]. At 26 hpf, we find no significant difference between pbx4b557-/- embryos and control siblings (Figure 4C,D,G). At 48 hpf, we find that both ventricular and atrial chambers show increased numbers of cardiomyocytes in pbx4b557-/- embryos compared to controls (Figure 4E–G). We also find that patterning of the outflow tract is disrupted in pbx4b557-/- embryos (Figure 4H–J). The outflow tract defects show variability: the outflow tract smooth muscle marker elastinb (elnb; [29]) is reduced in some pbx4b557-/- embryos (Figure 4I) and appears expanded in some pbx4b557-/- embryos (Figure 4J). Furthermore, we find evidence that Pbx4 is needed for proepicardial development, because pbx4b557-/- embryos show loss of expression of tbx18, a key marker of the proepicardium (Figure 4K,L) [39,40]. While our findings do not directly reveal the cause of the chamber and outflow tract dysmorphogeneis, these results suggest that Pbx4 may have multiple roles in heart development: an early role in promoting myocardial differentiation and morphogenesis, and later roles in repressing myocardial differentiation and regulating outflow tract and proepicardial formation.
Defects in zebrafish outflow tract development and elnb expression have been linked with defects in the second heart field (SHF), a source of later-differentiating myocardial progenitors after the initial cardiac tube is formed [30,41,42,43,44,45]. In particular, loss of the SHF marker ltbp3 leads to a reduced outflow tract and reduced elnb expression, while increased ltbp3 expression, seen in zebrafish embryos lacking cadm4, correlates with an expanded outflow tract [30,44,46]. We find that expression of ltbp3 is disrupted in pbx4b557-/- embryos (Figure 4M,N). However, in contrast to the varied patterns of elnb expression in pbx4b557-/- embryos (Figure 4H–J), we see a consistent, diffuse, defective ltbp3 expression pattern that appears broader but also weaker than that in controls (Figure 4M,N). Thus, these findings suggest that, while there appear to be defects in the formation of the SHF in pbx4b557-/- embryos, it is not yet clear how these defects lead to the variable outflow tract defects in pbx4b557-/- embryos.
Jdb 03 00093 g004a 1024Jdb 03 00093 g004b 1024
Figure 4. Cardiac chamber, outflow tract, and proepicardial development defects in pbx4 mutant embryos. (A,B) RNA in situ expression of cardiomyocyte differentiation gene myl7 (red) at 48 hpf in (A) control (n = 16) and (B) pbx4b557-/- (n = 4) embryos. V, ventricle. A, atrium. Arrow in (B) points to abnormal bulge in pbx4b557-/- ventricle. (C,D) Cardiomyocyte nuclei (magenta) in 26 hpf Tg(myl7:h2afva-mCherry)sd12 (C) control (n = 13) and (D) pbx4b557-/- (n = 9) embryos. (E,F) Cardiomyocyte nuclei (magenta) in 48 hpf Tg(myl7:h2afva-mCherry)sd12 (E) control (n = 9) and (F) pbx4b557-/- (n = 7) embryos. Tg(myh6:EGFP)s958 (green) is used to identify atrial cells. (G) Graph displaying cardiomyocyte nuclei count data at 26 hpf and 48 hpf. Error bars represent standard deviation. * P < 0.00003. (H,J) RNA in situ expression of outflow tract smooth muscle marker elnb (green) and myl7 (magenta) at 72 hpf in (H) control and (I,J) pbx4b557-/- embryos. In control embryos (n = 15), elnb expression appears as a ring (H). In pbx4b557-/- embryos, elnb expression can appear reduced (arrow in I; 5/9 embryos) or expanded and bifurcated (arrows in J; 4/9 embryos). (K,L) RNA in situ expression of tbx18 at 48 hpf in (K) control and (L) pbx4b557-/- embryos. tbx18 expression in pectoral fin (arrowhead) and proepicardial cells (arrow) is lost in pbx4b557-/- embryos (n = 9) compared to controls (n = 11), while facial expression (asterisk) is maintained. Hearts and embryos are shown in ventral view, anterior toward the top. (M,N) RNA in situ expression of ltbp3 at 24 hpf in (M) control and (N) pbx4b557-/- embryos. ltbp3 expression in second heart field domain (arrows) appears broader yet weaker in pbx4b557-/- embryos (n = 10, all weaker expression) compared to controls (n = 45, all similar), while notochord expression (arrowheads) is maintained. Embryos are shown in dorsal view, anterior towards the left.
Figure 4. Cardiac chamber, outflow tract, and proepicardial development defects in pbx4 mutant embryos. (A,B) RNA in situ expression of cardiomyocyte differentiation gene myl7 (red) at 48 hpf in (A) control (n = 16) and (B) pbx4b557-/- (n = 4) embryos. V, ventricle. A, atrium. Arrow in (B) points to abnormal bulge in pbx4b557-/- ventricle. (C,D) Cardiomyocyte nuclei (magenta) in 26 hpf Tg(myl7:h2afva-mCherry)sd12 (C) control (n = 13) and (D) pbx4b557-/- (n = 9) embryos. (E,F) Cardiomyocyte nuclei (magenta) in 48 hpf Tg(myl7:h2afva-mCherry)sd12 (E) control (n = 9) and (F) pbx4b557-/- (n = 7) embryos. Tg(myh6:EGFP)s958 (green) is used to identify atrial cells. (G) Graph displaying cardiomyocyte nuclei count data at 26 hpf and 48 hpf. Error bars represent standard deviation. * P < 0.00003. (H,J) RNA in situ expression of outflow tract smooth muscle marker elnb (green) and myl7 (magenta) at 72 hpf in (H) control and (I,J) pbx4b557-/- embryos. In control embryos (n = 15), elnb expression appears as a ring (H). In pbx4b557-/- embryos, elnb expression can appear reduced (arrow in I; 5/9 embryos) or expanded and bifurcated (arrows in J; 4/9 embryos). (K,L) RNA in situ expression of tbx18 at 48 hpf in (K) control and (L) pbx4b557-/- embryos. tbx18 expression in pectoral fin (arrowhead) and proepicardial cells (arrow) is lost in pbx4b557-/- embryos (n = 9) compared to controls (n = 11), while facial expression (asterisk) is maintained. Hearts and embryos are shown in ventral view, anterior toward the top. (M,N) RNA in situ expression of ltbp3 at 24 hpf in (M) control and (N) pbx4b557-/- embryos. ltbp3 expression in second heart field domain (arrows) appears broader yet weaker in pbx4b557-/- embryos (n = 10, all weaker expression) compared to controls (n = 45, all similar), while notochord expression (arrowheads) is maintained. Embryos are shown in dorsal view, anterior towards the left.
Jdb 03 00093 g004aJdb 03 00093 g004b

3.5. Pbx Expression Domains Support Multiple Roles for Pbx Proteins in Heart Development

The expression of Pbx proteins in premigratory neural crest cells has been shown to contribute to the outflow tract defects observed in mouse Pbx1 mutants, and Pbx proteins are also expressed in myocardial cells in the mouse embryo outflow tract, but Pbx expression in cardiomyocyte precursors has not been fully addressed [6,7]. To examine Pbx expression, we used a Pbx antiserum that was raised against zebrafish Pbx4 and crossreacts with Pbx2 [32]. At the 10 s stage, wild-type zebrafish embryos show nuclear Pbx expression in the ALPM and largely throughout the embryo (Figure 5A,B). At later stages, we used the Tg(myl7:EGFP)twu34 reporter to identify differentiated cardiomyocytes with nuclear Pbx expression at 21 s (19.5 hpf; Figure 5C,D) and 48 hpf (Figure 5G). While overall the Pbx staining appears predominantly nuclear, there may be some cytoplasmic Pbx expression as well (Figure 5D, for example). We find that, at 21 s, the Pbx immunostaining signal is largely absent from pbx4-/- embryos (Figure 5E,F), confirming that the Pbx antibody is predominantly recognizing Pbx4. These findings support a role for Pbx proteins acting in early cardiomyocytes to promote their differentiation. We also find heterogeneous expression of Pbx in the pan-cytokeratin-expressing proepicardial cells at 48 hpf near the ventricle of the heart (Figure 5H,I) [47]. Taken together, these results provide evidence of Pbx expression in early cardiomyocyte precursors, in differentiated cardiomyocytes, and in spatially-restricted pan-cytokeratin-expressing regions, supporting multiple roles for Pbx proteins in heart development.

4. Discussion

4.1. Pbx Proteins Promote Early Myocardial Differentiation and Morphogenesis

Our study provides support for an early role for Pbx proteins in promoting myocardial differentiation by showing that pbx4 mutant embryos have delayed activation of myocardial differentiation (Figure 2) and that Pbx proteins are expressed in both cardiomyocyte precursors and differentiated cardiomyocytes (Figure 5). The delayed onset of cardiomyocyte differentiation markers and the delayed morphogenesis of myocardial cells during cardiac fusion and heart tube formation that we observe in pbx4 mutant embryos also provides further support that myocardial differentiation and morphogenesis are intimately linked [1,4,48,49]. Studies in mice and other model organisms have revealed varied roles for Pbx proteins in promoting and inhibiting cellular differentiation in many developmental contexts [13,50]. Studies of Pbx functions in skeletal muscle have demonstrated the critical role of Pbx proteins in promoting skeletal muscle differentiation, in particular through acting as pioneer factors for Myod [14,15,16,51,52,53,54]. Our studies here not only demonstrate that Pbx proteins promote early myocardial differentiation, but also reveal that pbx4 appears to inhibit later myocardial differentiation. Even though we have shown that Pbx proteins can bind the zebrafish myl7 promoter [8], how Pbx4 activates or represses myocardial differentiation genes at different stages of development is not yet known.
It is not yet clear whether the role of Pbx proteins in promoting early myocardial differentiation is conserved. Previous studies in mouse embryos, using combinations of Pbx gene null alleles, have shown that Pbx genes are required for outflow tract development [6,7], and we show that zebrafish pbx4 is needed for outflow tract development (Figure 4). However, because of early lethality of certain allelic combinations, the full requirements for Pbx proteins in mouse heart development have not yet been determined. Thus, studies have not yet directly addressed whether early myocardial differentiation is affected in Pbx-deficient mice.
Jdb 03 00093 g005 1024
Figure 5. Analysis of Pbx expression during zebrafish cardiac development. (A–G) Pbx immunostaining at (A–B) 10 s (14 hpf), (C–F) 21 s (19.5 hpf), and (G–H) 48 hpf. (A–B) Pbx expression (magenta) in wild type 10 s embryo co-stained with Hoechst to label nuclei (green). (A) Dorsal view, anterior to the left. The line in (A), approximately at the level of hindbrain rhombomere 3, shows where we took an optical cross-section view for (B). Arrows in (B) show Pbx expression in ALPM cells next to the neural tube (nt in A,B). (C–F) Pbx expression (magenta) in Tg(myl7:EGFP)twu34 (green) 21 s (C–D) control embryo and (E–F) pbx4-/- embryo, at low (C,E) and high (D,F) magnification. Arrow in (D) points to cells co-expressing myl7:EGFP and Pbx. Dorsal view, anterior to the left. (G) Pbx expression (magenta) in Tg(myl7:EGFP)twu34 (green) 48 hpf embryo. Ventral view, anterior to the top. V, ventricle. A, atrium. (H–I) Pbx expression (magenta) in wild-type 48 hpf embryo co-stained for proepicardial pan-cytokeratin expression (green) and myocardial cells (MF20, red), at low (H) and high (I) magnification. V, ventricle. Arrows in (H,I) point to two pan-cytokeratin-expressing cells that do not express Pbx, compared to neighboring cardiomyocytes and pan-cytokeratin/Pbx co-expressing cells (arrowheads, I). Scale bar for (A): 100 µm. Scale bar for (B–D): 50 µm. Scale bar for (H): 10 µm.
Figure 5. Analysis of Pbx expression during zebrafish cardiac development. (A–G) Pbx immunostaining at (A–B) 10 s (14 hpf), (C–F) 21 s (19.5 hpf), and (G–H) 48 hpf. (A–B) Pbx expression (magenta) in wild type 10 s embryo co-stained with Hoechst to label nuclei (green). (A) Dorsal view, anterior to the left. The line in (A), approximately at the level of hindbrain rhombomere 3, shows where we took an optical cross-section view for (B). Arrows in (B) show Pbx expression in ALPM cells next to the neural tube (nt in A,B). (C–F) Pbx expression (magenta) in Tg(myl7:EGFP)twu34 (green) 21 s (C–D) control embryo and (E–F) pbx4-/- embryo, at low (C,E) and high (D,F) magnification. Arrow in (D) points to cells co-expressing myl7:EGFP and Pbx. Dorsal view, anterior to the left. (G) Pbx expression (magenta) in Tg(myl7:EGFP)twu34 (green) 48 hpf embryo. Ventral view, anterior to the top. V, ventricle. A, atrium. (H–I) Pbx expression (magenta) in wild-type 48 hpf embryo co-stained for proepicardial pan-cytokeratin expression (green) and myocardial cells (MF20, red), at low (H) and high (I) magnification. V, ventricle. Arrows in (H,I) point to two pan-cytokeratin-expressing cells that do not express Pbx, compared to neighboring cardiomyocytes and pan-cytokeratin/Pbx co-expressing cells (arrowheads, I). Scale bar for (A): 100 µm. Scale bar for (B–D): 50 µm. Scale bar for (H): 10 µm.
Jdb 03 00093 g005
Pbx proteins have overlapping expression patterns and redundant roles [6,12,55,56,57]. In our previous studies, we used antisense morpholinos (MOs) to knock down both zebrafish pbx2 and pbx4, and we showed that pbx2-MO;pbx4-MO zebrafish embryos have delayed differentiation and migration of myocardial precursor cells and defective myocardial morphogenesis and chamber formation [8]. Our current study demonstrates that pbx4b557-/- embryos also have delayed cardiomyocyte differentiation and morphogenesis. The myocardial differentiation phenotype appears less severe in pbx4b557-/- embryos than in pbx2-MO;pbx4-MO embryos, pointing to a requirement for pbx2 in addition to pbx4 in myocardial differentiation. For example, nppa expression, which is absent in pbx2-MO;pbx4-MO embryos at 28 hpf [8], is present but reduced in pbx4b557-/- embryos (Figure 2). It is possible that the variability that we observe in pbx4b557-/- embryos, for example in the outflow tract phenotype (Figure 4), is due to variable compensation by other pbx genes. Therefore, in order to fully address the functions of Pbx proteins in heart development, it will be critical to examine zebrafish mutant combinations for additional pbx genes in future studies. Indeed, our preliminary studies show that zebrafish pbx2;pbx4 double mutant embryos exhibit more severe and more consistent defects in myocardial differentiation and outflow tract formation than pbx4 mutants [58]. Recent studies have found that zebrafish morpholino knockdown and mutant phenotypes often do not correspond [59,60]. While our zebrafish pbx gene morpholino and mutant studies do generally correspond, to fully address pbx gene requirements, we favor the use of mutant strains for future zebrafish pbx gene studies.

4.2. Pbx4-dependent Patterning of the Developing Outflow Tract

Previous studies have shown that loss of different combinations of Pbx genes in mouse embryos can lead to a spectrum of outflow tract defects [6,7]. These studies in mouse embryos also demonstrated that Pbx proteins are expressed in many cell types involved in outflow tract development. In particular, Pbx1 expression in pre-migratory cardiac neural crest cells directly activates expression of Pax3, which is required for cardiac neural crest cells to properly contribute to outflow tract development [7,61]. Pbx proteins are also expressed in vascular smooth muscle cells of the outflow tract and great arteries in mouse embryos [6,7]. We find that zebrafish pbx4 is required for proper patterning of the smooth muscle elnb-expressing domain of the outflow tract (Figure 4). In contrast to the loss of elnb expression in the outflow tract observed in loss-of-function studies for zebrafish ltbp3, nkx2.5, and tbx1 [30,44,45], we observed a variable mispatterning of the elnb domain along the outflow tract in pbx4 mutants (Figure 4). Loss of zebrafish cadm4 function leads to an expansion of the outflow tract, although elnb expression was not examined [46]. In future studies, it will be important to determine whether pbx4 is acting upstream or downstream of tbx1 and these other factors involved in outflow tract development.
Our results point to two potential mechanisms by which pbx4 might regulate outflow tract development. First, we observe an expansion of hand2 expression in the ALPM of pbx4 mutants (Figure 3). Early SHF cells arise from hand2-expressing cells in the early ALPM [41,44]. The expanded hand2 expression domain in pbx4 mutants could, thus, provide a possible source of additional SHF cells and, indeed, our results with ltbp3 expression indicate a possible expanded SHF (Figure 4). An expanded SHF could lead to the increased cardiomyocytes that we observe at 48 hpf as well as the expanded elnb expression that we observe in some pbx4 mutant embryos (Figure 4). Second, the opposite effects that we observe in pbx4 mutants on early versus later cardiomyocyte differentiation is similar to the dual effects of bone morphogenetic protein (BMP) signaling on early versus later cardiomyocyte differentiation, and BMP signaling regulates outflow tract formation [41,62,63]. In future studies, it will be important to examine how pbx4 regulates hand2 expression and interacts with BMP signaling.
A recent study has found that Pbx1 directly regulates PDGFRβ expression in vascular smooth muscle progenitors in mouse kidney development [64]. PDGFRβ expression is also required for coronary vascular smooth muscle development and for cardiac neural crest cell contributions to outflow tract development in mouse embryos [65,66,67]. Whether PDGFRβ regulation is conserved in zebrafish and contributes to the phenotypes we observe in pbx4 mutants remains to be determined. Genetic mosaic studies in zebrafish embryos should help establish in which cell types Pbx4 functions to regulate outflow tract development. Studies implicating Pbx proteins in outflow tract malformations in human congenital heart defects further underscore the importance of understanding how Pbx proteins function in heart development [68].

4.3. Pbx Expression Heterogeneity among Pan-Cytokeratin-Expressing Cells Adjacent to the Ventricle

Previous studies have demonstrated broad expression of Pbx proteins in many cell types involved in heart development [6,7]. Our zebrafish Pbx immunostaining data is in agreement with these studies and other previous reports of broad Pbx expression (Figure 5) [13,19]. While overall our Pbx immunostaining appears predominantly nuclear, there may also be some cytoplasmic Pbx expression (Figure 5). Nuclear and cytoplasmic expression of Pbx would be consistent with earlier studies showing that Pbx protein localization is regulated during development [69,70]. We were able to make use of pan-cytokeratin expression, a well-established marker of the developing epicardium in many species [39,71,72], to ask whether Pbx proteins are expressed in developing zebrafish proepicardial cells. We noticed that there is a subpopulation of pan-cytokeratin-expressing cells near the ventricle at 48 hpf that is devoid of nuclear Pbx expression (Figure 5). We also noticed a loss of tbx18 expression in the developing proepicardial region in pbx4b557-/- embryos at 48 hpf (Figure 4). The proepicardium gives rise to the epicardium, a mesothelial lining of the heart that is needed for proper heart and coronary vessel development and that has been implicated in cardiac regeneration [73,74,75]. The heterogeneity of Pbx expression among pan-cytokeratin expressing cells near the ventricle thus offers a platform for investigating potential actions of Pbx in proepicardial and epicardial cells during cardiac development and regeneration. Whether reduced tbx18 expression (Figure 4) represents the loss of an epicardial subset, or indicates tbx18 transcription is directly regulated by Pbx proteins, requires further work. What roles Pbx expression heterogeneity among cytokeratin-positive cells may play in the development and diversity of proepicardial cell fates also remains to be elucidated in future studies.

5. Conclusions

We show that zebrafish pbx4 mutant embryos exhibit delayed onset of myocardial differentiation, delayed myocardial morphogenesis, and dysmorphic patterning of the ventricle and atrium, consistent with our previous Pbx knock-down studies. In addition, we find that pbx4 mutant larvae have aberrant outflow tracts and defective expression of the proepicardial marker tbx18. We also present evidence for Pbx expression in cardiomyocyte precursors as well as heterogeneous Pbx expression among the pan-cytokeratin-expressing proepicardial cells near the developing ventricle. In conclusion, our data show that Pbx4 is required for the proper temporal activation of myocardial differentiation and establish a basis for studying additional roles of Pbx factors in heart development.

Acknowledgments

We thank the following colleagues for generously providing reagents: Neil Chi, Fred Keeley, Charles Sagerström, Didier Stainier, and Debbie Yelon. The MF20 antibody was obtained from the Developmental Studies Hybridoma Bank. We thank Jerry Ament and the SCRI Aquatics Facility staff for expert zebrafish maintenance. This work was supported by the Seattle Children’s Myocardial Regeneration Initiative and by grants from the American Heart Association (14BGIA18190004 to L.M.) and the National Institutes of Health (HL123650 to M.W.M). R.M.K. was supported by the NIH NIDDK T32007467 Research Training in Renal Disease.

Author Contributions

R.M.K., M.W.M. and L.M. conceived the experiments. R.M.K., J.G.R., G.H.F. and L.M. performed the experiments. X.R.D. provided technical input and advice. R.M.K., J.G.R., G.H.F., M.W.M. and L.M. analyzed the data. R.M.K. and L.M. wrote the paper with input from all authors.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Yelon, D. Cardiac patterning and morphogenesis in zebrafish. Dev. Dyn. 2001, 222, 552–563. [Google Scholar] [CrossRef] [PubMed]
  2. Evans, S.M.; Yelon, D.; Conlon, F.L.; Kirby, M.L. Myocardial lineage development. Circ. Res. 2010, 107, 1428–1444. [Google Scholar] [CrossRef] [PubMed]
  3. Kupperman, E.; Songzhu, A.; Osborne, N.; Waldron, S.; Stainier, D.Y.R. A sphingosine-1-phosphate receptor regulates cell migration during vertebrate heart development. Nature 2000, 406, 192–195. [Google Scholar] [PubMed]
  4. Glickman, N.S.; Yelon, D. Cardiac development in zebrafish: Coordination of form and function. Semin. Cell Dev. Biol. 2002, 13, 507–513. [Google Scholar] [CrossRef] [PubMed]
  5. Bakkers, J.; Verhoeven, M.C.; Abdelilah-Seyfried, S. Shaping the zebrafish heart: From left-right axis specification to epithelial tissue morphogenesis. Dev. Biol. 2009, 330, 213–220. [Google Scholar] [CrossRef] [PubMed]
  6. Stankunas, K.; Shang, C.; Twu, K.Y.; Kao, S.C.; Jenkins, N.A.; Copeland, N.G.; Sanyal, M.; Selleri, L.; Cleary, M.L.; Chang, C.P. Pbx/Meis deficiencies demonstrate multigenetic origins of congenital heart disease. Circ. Res. 2008, 103, 702–709. [Google Scholar] [CrossRef] [PubMed]
  7. Chang, C.P.; Stankunas, K.; Shang, C.; Kao, S.C.; Twu, K.Y.; Cleary, M.L. Pbx1 functions in distinct regulatory networks to pattern the great arteries and cardiac outflow tract. Development 2008, 135, 3577–3586. [Google Scholar] [CrossRef] [PubMed]
  8. Maves, L.; Tyler, A.; Moens, C.B.; Tapscott, S.J. Pbx acts with Hand2 in early myocardial differentiation. Dev. Biol. 2009, 333, 409–418. [Google Scholar] [CrossRef] [PubMed]
  9. Paige, S.L.; Thomas, S.; Stoick-Cooper, C.L.; Wang, H.; Maves, L.; Sandstrom, R.; Pabon, L.; Reinecke, H.; Pratt, G.; Keller, G.; et al. A temporal chromatin signature in human embryonic stem cells identifies regulators of cardiac development. Cell 2012, 151, 221–232. [Google Scholar] [CrossRef] [PubMed]
  10. Wamstad, J.A.; Alexander, J.M.; Truty, R.M.; Shrikumar, A.; Li, F.; Eilertson, K.E.; Ding, H.; Wylie, J.N.; Pico, A.R.; Capra, J.A.; et al. Dynamic and coordinated epigenetic regulation of developmental transitions in the cardiac lineage. Cell 2012, 151, 206–220. [Google Scholar] [CrossRef] [PubMed]
  11. Mahmoud, A.I.; Kocabas, F.; Muralidhar, S.A.; Kimura, W.; Koura, A.S.; Thet, S.; Porrello, E.R.; Sadek, H.A. Meis1 regulates postnatal cardiomyocyte cell cycle arrest. Nature 2013, 497, 249–253. [Google Scholar] [CrossRef] [PubMed]
  12. Waskiewicz, A.J.; Rikhof, H.A.; Moens, C.B. Eliminating zebrafish pbx proteins reveals a hindbrain ground state. Dev. Cell 2002, 3, 723–733. [Google Scholar] [CrossRef]
  13. Moens, C.B.; Selleri, L. Hox cofactors in vertebrate development. Dev. Biol. 2006, 291, 193–206. [Google Scholar] [CrossRef] [PubMed]
  14. Berkes, C.A.; Bergstrom, D.A.; Penn, B.H.; Seaver, K.J.; Knoepfler, P.S.; Tapscott, S.J. Pbx marks genes for activation by MyoD indicating a role for a homeodomain protein in establishing myogenic potential. Mol. Cell 2004, 14, 465–477. [Google Scholar] [CrossRef]
  15. Maves, L.; Waskiewicz, A.J.; Paul, B.; Cao, Y.; Tyler, A.; Moens, C.B.; Tapscott, S.J. Pbx homeodomain proteins direct Myod activity to promote fast-muscle differentiation. Development 2007, 134, 3371–3382. [Google Scholar] [CrossRef] [PubMed]
  16. Fong, A.P.; Yao, Z.; Zhong, J.W.; Johnson, N.M.; Farr, G.H., III; Maves, L.; Tapscott, S.J. Conversion of MyoD to a neurogenic factor: Binding site specificity determines lineage. Cell Rep. 2015, 10, 1937–1946. [Google Scholar] [CrossRef] [PubMed]
  17. He, A.; Kong, S.W.; Ma, Q.; Pu, W.T. Co-occupancy by multiple cardiac transcription factors identifies transcriptional enhancers active in heart. Proc. Natl. Acad. Sci. USA 2011, 108, 5632–5637. [Google Scholar] [CrossRef] [PubMed]
  18. Westerfield, M. The Zebrafish Book. A Guide for the Laboratory Use of Zebrafish (Danio rerio), 5th ed.; University of Oregon Press: Eugene, OR, USA, 2007. [Google Scholar]
  19. Pöpperl, H.; Rikhof, H.; Chang, H.; Haffter, P.; Kimmel, C.B.; Moens, C.B. lazarus is a novel pbx gene that globally mediates hox gene function in zebrafish. Mol. Cell 2000, 6, 255–267. [Google Scholar] [CrossRef]
  20. Huang, C.J.; Tu, C.T.; Hsiao, C.D.; Hsieh, F.J.; Tsai, H.J. Germ-line transmission of a myocardium-specific GFP transgene reveals critical regulatory elements in the cardiac myosin light chain 2 promoter of zebrafish. Dev. Dyn. 2003, 228, 30–40. [Google Scholar] [CrossRef] [PubMed]
  21. Schumacher, J.A.; Bloomekatz, J.; Garavito-Aguilar, Z.V.; Yelon, D. Tal1 regulates the formation of intercellular junctions and the maintenance of identity in the endocardium. Dev. Biol. 2013, 383, 214–226. [Google Scholar] [CrossRef] [PubMed]
  22. Zhang, R.; Han, P.; Yang, H.; Ouyang, K.; Lee, D.; Lin, Y.F.; Ocorr, K.; Kang, G.; Chen, J.; Stainier, D.Y.; et al. In vivo cardiac reprogramming contributes to zebrafish heart regeneration. Nature 2013, 498, 497–501. [Google Scholar] [CrossRef] [PubMed]
  23. Oxtoby, E.; Jowett, T. Cloning of the zebrafish krox-20 gene (krx-20) and its expression during hindbrain development. Nucleic Acids Res. 1993, 21, 1087–1095. [Google Scholar] [CrossRef] [PubMed]
  24. Sehnert, A.J.; Huq, A.; Weinstein, B.M.; Walker, C.; Fishman, M.; Stainier, D.Y. Cardiac troponin T is essential in sarcomere assembly and cardiac contractility. Nat. Genet. 2002, 31, 106–110. [Google Scholar] [CrossRef] [PubMed]
  25. Yelon, D.; Horne, S.A.; Stainier, D.Y. Restricted expression of cardiac myosin genes reveals regulated aspects of heart tube assembly in zebrafish. Dev. Biol. 1999, 214, 23–37. [Google Scholar] [CrossRef] [PubMed]
  26. Berdougo, E.; Coleman, H.; Lee, D.H.; Stainier, D.Y.; Yelon, D. Mutation of weak atrium/atrial myosin heavy chain disrupts atrial function and influences ventricular morphogenesis in zebrafish. Development 2003, 130, 6121–6129. [Google Scholar] [CrossRef] [PubMed]
  27. Reiter, J.F.; Alexander, J.; Rodaway, A.; Yelon, D.; Patient, R.; Holder, N.; Stainier, D.Y. Gata5 is required for the development of the heart and endoderm in zebrafish. Genes Dev. 1999, 13, 2983–2995. [Google Scholar] [CrossRef] [PubMed]
  28. Yelon, D.; Ticho, B.; Halpern, M.E.; Ruvinsky, I.; Ho, R.K.; Silver, L.M.; Stainier, D.Y. The bHLH transcription factor hand2 plays parallel roles in zebrafish heart and pectoral fin development. Development 2000, 127, 2573–2582. [Google Scholar] [PubMed]
  29. Miao, M.; Bruce, A.E.; Bhanji, T.; Davis, E.C.; Keeley, F.W. Differential expression of two tropoelastin genes in zebrafish. Matrix Biol. 2007, 26, 115–124. [Google Scholar] [CrossRef] [PubMed]
  30. Zhou, Y.; Cashman, T.J.; Nevis, K.R.; Obregon, P.; Carney, S.A.; Liu, Y.; Gu, A.; Mosimann, C.; Sondalle, S.; Peterson, R.E.; et al. Latent TGF-β binding protein 3 identifies a second heart field in zebrafish. Nature 2011, 474, 645–648. [Google Scholar] [CrossRef] [PubMed]
  31. Talbot, J.C.; Johnson, S.L.; Kimmel, C.B. Hand2 and Dlx genes specify dorsal, intermediate and ventral domains within zebrafish pharyngeal arches. Development 2010, 137, 2507–2517. [Google Scholar] [CrossRef] [PubMed]
  32. Choe, S.K.; Lu, P.; Nakamura, M.; Lee, J.; Sagerström, C.G. Meis cofactors control HDAC and CBP accessibility at Hox-regulated promoters during zebrafish embryogenesis. Dev. Cell 2009, 17, 561–567. [Google Scholar] [CrossRef] [PubMed]
  33. Feng, X.; Adiarte, E.G.; Devoto, S.H. Hedgehog acts directly on the zebrafish dermomyotome to promote myogenic differentiation. Dev. Biol. 2006, 300, 736–746. [Google Scholar] [CrossRef] [PubMed]
  34. Dent, J.A.; Polson, A.G.; Klymkowsky, M.W. A whole-mount immunocytochemical analysis of the expression of the intermediate filament protein vimentin in Xenopus. Development 1989, 105, 61–74. [Google Scholar] [PubMed]
  35. Drummond, I.A.; Davidson, A.J. Zebrafish kidney development. Methods Cell Biol. 2010, 100, 233–260. [Google Scholar] [PubMed]
  36. Fiji. Available online: http://fiji.sc/Fiji (accessed on 9 November 2015).
  37. Preibisch, S.; Saalfeld, S.; Tomancak, P. Globally optimal stitching of tiled 3D microscopic image acquisitions. Bioinformatics 2009, 25, 1463–1465. [Google Scholar] [CrossRef] [PubMed]
  38. Weinberg, E.S.; Allende, M.L.; Kelly, C.S.; Abdelhamid, A.; Murakami, T.; Andermann, P.; Doerre, O.G.; Grunwald, D.J.; Riggleman, B. Developmental regulation of zebrafish MyoD in wild-type, no tail and spadetail embryos. Development 1996, 122, 271–280. [Google Scholar] [PubMed]
  39. Kraus, F.; Haenig, B.; Kispert, A. Cloning and expression analysis of the mouse T-box gene Tbx18. Mech. Dev. 2001, 100, 83–86. [Google Scholar] [CrossRef]
  40. Liu, J.; Stainier, D.Y. Tbx5 and Bmp signaling are essential for proepicardium specification in zebrafish. Circ. Res. 2010, 106, 1818–1828. [Google Scholar] [CrossRef] [PubMed]
  41. Hami, D.; Grimes, A.C.; Tsai, H.J.; Kirby, M.L. Zebrafish cardiac development requires a conserved secondary heart field. Development 2011, 138, 2389–2398. [Google Scholar] [CrossRef] [PubMed]
  42. Lazic, S.; Scott, I.C. Mef2cb regulates late myocardial cell addition from a second heart field-like population of progenitors in zebrafish. Dev. Biol. 2011, 354, 123–133. [Google Scholar] [CrossRef] [PubMed]
  43. Hinits, Y.; Pan, L.; Walker, C.; Dowd, J.; Moens, C.B.; Hughes, S.M. Zebrafish Mef2ca and Mef2cb are essential for both first and second heart field cardiomyocyte differentiation. Dev. Biol. 2012, 369, 199–210. [Google Scholar] [CrossRef] [PubMed]
  44. Guner-Ataman, B.; Paffett-Lugassy, N.; Adams, M.S.; Nevis, K.R.; Jahangiri, L.; Obregon, P.; Kikuchi, K.; Poss, K.D.; Burns, C.E.; Burns, C.G. Zebrafish second heart field development relies on progenitor specification in anterior lateral plate mesoderm and nkx2.5 function. Development 2013, 140, 1353–1363. [Google Scholar] [CrossRef] [PubMed]
  45. Nevis, K.; Obregon, P.; Walsh, C.; Guner-Ataman, B.; Burns, C.G.; Burns, C.E. Tbx1 is required for second heart field proliferation in zebrafish. Dev. Dyn. 2013, 242, 550–559. [Google Scholar] [CrossRef] [PubMed]
  46. Zeng, X.X.; Yelon, D. Cadm4 restricts the production of cardiac outflow tract progenitor cells. Cell Rep. 2014, 7, 951–960. [Google Scholar] [CrossRef] [PubMed]
  47. Peralta, M.; Steed, E.; Harlepp, S.; González-Rosa, J.M.; Monduc, F.; Ariza-Cosano, A.; Cortés, A.; Rayón, T.; Gómez-Skarmeta, J.L.; Zapata, A.; et al. Heartbeat-driven pericardiac fluid forces contribute to epicardium morphogenesis. Curr. Biol. 2013, 23, 1726–1735. [Google Scholar] [PubMed]
  48. Trinh, L.A.; Yelon, D.; Stainier, D.Y. Hand2 regulates epithelial formation during myocardial differentiation. Curr. Biol. 2005, 15, 441–446. [Google Scholar] [CrossRef] [PubMed]
  49. Garavito-Aguilar, Z.V.; Riley, H.E.; Yelon, D. Hand2 ensures an appropriate environment for cardiac fusion by limiting Fibronectin function. Development 2010, 137, 3215–3220. [Google Scholar] [CrossRef] [PubMed]
  50. Cerdá-Esteban, N.; Spagnoli, F.M. Glimpse into Hox and tale regulation of cell differentiation and reprogramming. Dev. Dyn. 2014, 243, 76–87. [Google Scholar] [CrossRef] [PubMed]
  51. De la Serna, I.L.; Ohkawa, Y.; Berkes, C.A.; Bergstrom, D.A.; Dacwag, C.S.; Tapscott, S.J.; Imbalzano, A.N. MyoD targets chromatin remodeling complexes to the myogenin locus prior to forming a stable DNA-bound complex. Mol. Cell. Biol. 2005, 25, 3997–4009. [Google Scholar] [CrossRef] [PubMed]
  52. Bryantsev, A.L.; Duong, S.; Brunetti, T.M.; Chechenova, M.B.; Lovato, T.L.; Nelson, C.; Shaw, E.; Uhl, J.D.; Gebelein, B.; Cripps, R.M. Extradenticle and homothorax control adult muscle fiber identity in Drosophila. Dev. Cell 2012, 23, 664–673. [Google Scholar] [CrossRef] [PubMed]
  53. Yao, Z.; Farr, G.H., III; Tapscott, S.J.; Maves, L. Pbx and Prdm1a transcription factors differentially regulate subsets of the fast skeletal muscle program in zebrafish. Biol. Open 2013, 2, 546–555. [Google Scholar] [CrossRef] [PubMed]
  54. Cho, O.H.; Mallappa, C.; Hernández-Hernández, J.M.; Rivera-Pérez, J.A.; Imbalzano, A.N. Contrasting roles for MyoD in organizing myogenic promoter structures during embryonic skeletal muscle development. Dev. Dyn. 2015, 244, 43–55. [Google Scholar] [CrossRef] [PubMed]
  55. Capellini, T.D.; di Giacomo, G.; Salsi, V.; Brendolan, A.; Ferretti, E.; Srivastava, D.; Zappavigna, V.; Selleri, L. Pbx1/Pbx2 requirement for distal limb patterning is mediated by the hierarchical control of Hox gene spatial distribution and Shh expression. Development 2006, 133, 2263–2273. [Google Scholar] [CrossRef] [PubMed]
  56. Ferretti, E.; Li, B.; Zewdu, R.; Wells, V.; Hebert, J.M.; Karner, C.; Anderson, M.J.; Williams, T.; Dixon, J.; Dixon, M.J.; et al. A conserved Pbx-Wnt-p63-Irf6 regulatory module controls face morphogenesis by promoting epithelial apoptosis. Dev. Cell 2011, 21, 627–641. [Google Scholar] [CrossRef] [PubMed]
  57. Koss, M.; Bolze, A.; Brendolan, A.; Saggese, M.; Capellini, T.D.; Bojilova, E.; Boisson, B.; Prall, O.W.; Elliott, D.A.; Solloway, M.; et al. Congenital asplenia in mice and humans with mutations in a Pbx/Nkx2-5/p15 module. Dev. Cell 2012, 22, 913–926. [Google Scholar] [CrossRef] [PubMed]
  58. Farr, G.H., III; Maves, L.; Seattle Children’s Research Institute, Seattle, WA, USA. Unpublished work. 2015.
  59. Kok, F.O.; Shin, M.; Ni, C.W.; Gupta, A.; Grosse, A.S.; van Impel, A.; Kirchmaier, B.C.; Peterson-Maduro, J.; Kourkoulis, G.; Male, I.; et al. Reverse genetic screening reveals poor correlation between morpholino-induced and mutant phenotypes in zebrafish. Dev. Cell 2015, 32, 97–108. [Google Scholar] [CrossRef] [PubMed]
  60. Rossi, A.; Kontarakis, Z.; Gerri, C.; Nolte, H.; Hölper, S.; Krüger, M.; Stainier, D.Y. Genetic compensation induced by deleterious mutations but not gene knockdowns. Nature 2015, 524, 230–233. [Google Scholar] [CrossRef] [PubMed]
  61. Hutson, M.R.; Kirby, M.L. Neural crest and cardiovascular development: A 20-year perspective. Birth Defects Res. C Embryo Today 2003, 69, 2–13. [Google Scholar] [CrossRef] [PubMed]
  62. Prall, O.W.; Menon, M.K.; Solloway, M.J.; Watanabe, Y.; Zaffran, S.; Bajolle, F.; Biben, C.; McBride, J.J.; Robertson, B.R.; Chaulet, H.; et al. An Nkx2-5/Bmp2/Smad1 negative feedback loop controls heart progenitor specification and proliferation. Cell 2007, 128, 947–959. [Google Scholar] [CrossRef] [PubMed]
  63. De Pater, E.; Ciampricotti, M.; Priller, F.; Veerkamp, J.; Strate, I.; Smith, K.; Lagendijk, A.K.; Schilling, T.F.; Herzog, W.; Abdelilah-Seyfried, S.; et al. Bmp signaling exerts opposite effects on cardiac differentiation. Circ Res. 2012, 110, 578–587. [Google Scholar] [CrossRef] [PubMed]
  64. Hurtado, R.; Zewdu, R.; Mtui, J.; Liang, C.; Aho, R.; Kurylo, C.; Selleri, L.; Herzlinger, D. Pbx1-dependent control of VMC differentiation kinetics underlies gross renal vascular patterning. Development 2015, 142, 2653–2664. [Google Scholar] [CrossRef] [PubMed]
  65. Lu, J.; Landerholm, T.E.; Wei, J.S.; Dong, X.R.; Wu, S.P.; Liu, X.; Nagata, K.; Inagaki, M.; Majesky, M.W. Coronary smooth muscle differentiation from proepicardial cells requires rhoA-mediated actin reorganization and p160 rho-kinase activity. Dev. Biol. 2001, 240, 404–418. [Google Scholar] [CrossRef] [PubMed]
  66. Richarte, A.M.; Mead, H.B.; Tallquist, M.D. Cooperation between the PDGF receptors in cardiac neural crest cell migration. Dev. Biol. 2007, 306, 785–796. [Google Scholar] [CrossRef] [PubMed]
  67. Mellgren, A.M.; Smith, C.L.; Olsen, G.S.; Eskiocak, B.; Zhou, B.; Kazi, M.N.; Ruiz, F.R.; Pu, W.T.; Tallquist, M.D. Platelet-derived growth factor receptor beta signaling is required for efficient epicardial cell migration and development of two distinct coronary vascular smooth muscle cell populations. Circ. Res. 2008, 103, 1393–1401. [Google Scholar] [CrossRef] [PubMed]
  68. Arrington, C.B.; Dowse, B.R.; Bleyl, S.B.; Bowles, N.E. Non-synonymous variants in pre-B cell leukemia homeobox (PBX) genes are associated with congenital heart defects. Eur. J. Med. Genet. 2012, 55, 235–237. [Google Scholar] [CrossRef] [PubMed]
  69. Mann, R.S.; Abu-Shaar, M. Nuclear import of the homeodomain protein extradenticle in response to Wg and Dpp signaling. Nature 1996, 383, 630–633. [Google Scholar] [CrossRef] [PubMed]
  70. Gonzálaz-Crespo, S.; Abu-Shaar, M.; Torres, M.; Martínez-A, C.; Mann, R.S.; Morata, G. Antagonism between extradenticle function and Hedgehog signaling in the developing limb. Nature 1998, 394, 196–200. [Google Scholar] [CrossRef] [PubMed]
  71. Vrancken Peeters, M.P.; Mentink, M.M.; Poelmann, R.E.; Gittenberger-de Groot, A.C. Cytokeratins as a marker for epicardial formation in the quail embryo. Anat. Embryol. 1995, 191, 503–508. [Google Scholar] [PubMed]
  72. Dettman, R.W.; Denetclaw, W., Jr.; Ordahl, C.P.; Bristow, J. Common epicardial origin of coronary vascular smooth muscle, perivascular fibroblasts, and intermyocardial fibroblasts in the avian heart. Dev. Biol. 1998, 193, 169–181. [Google Scholar] [CrossRef] [PubMed]
  73. Schlueter, J.; Brand, T. Epicardial progenitor cells in cardiac development and regeneration. J. Cardiovasc. Transl. Res. 2012, 5, 641–653. [Google Scholar] [CrossRef] [PubMed]
  74. Wu, S.P.; Dong, X.R.; Regan, J.N.; Su, C.; Majesky, M.W. Tbx18 regulates development of the epicardium and coronary vessels. Dev. Biol. 2013, 383, 307–320. [Google Scholar] [CrossRef] [PubMed]
  75. Masters, M.; Riley, P.R. The epicardium signals the way towards heart regeneration. Stem Cell Res. 2014, 13, 683–692. [Google Scholar] [CrossRef] [PubMed]

Share and Cite

MDPI and ACS Style

Kao, R.M.; Rurik, J.G.; III, G.H.F.; Dong, X.R.; Majesky, M.W.; Maves, L. Pbx4 is Required for the Temporal Onset of Zebrafish Myocardial Differentiation. J. Dev. Biol. 2015, 3, 93-111. https://doi.org/10.3390/jdb3040093

AMA Style

Kao RM, Rurik JG, III GHF, Dong XR, Majesky MW, Maves L. Pbx4 is Required for the Temporal Onset of Zebrafish Myocardial Differentiation. Journal of Developmental Biology. 2015; 3(4):93-111. https://doi.org/10.3390/jdb3040093

Chicago/Turabian Style

Kao, Robert M., Joel G. Rurik, Gist H. Farr III, Xiu Rong Dong, Mark W. Majesky, and Lisa Maves. 2015. "Pbx4 is Required for the Temporal Onset of Zebrafish Myocardial Differentiation" Journal of Developmental Biology 3, no. 4: 93-111. https://doi.org/10.3390/jdb3040093

APA Style

Kao, R. M., Rurik, J. G., III, G. H. F., Dong, X. R., Majesky, M. W., & Maves, L. (2015). Pbx4 is Required for the Temporal Onset of Zebrafish Myocardial Differentiation. Journal of Developmental Biology, 3(4), 93-111. https://doi.org/10.3390/jdb3040093

Article Metrics

Back to TopTop